Literature DB >> 7704581

Developmental patterning. The Hox code out on a limb.

A Graham1.   

Abstract

Studies of limb development in mice lacking particular hoxd genes have cast doubt on the suggestion that Hox genes combine to control vertebrate morphogenesis by specifying positional information in a 'Hox code'.

Entities:  

Mesh：

Year:  1994        PMID： 7704581     DOI： 10.1016/s0960-9822(00)00256-6

Source DB:  PubMed          Journal:  Curr Biol        ISSN： 0960-9822            Impact factor:   10.834


  6 in total

1.  Germline mutations in HOXB13 and prostate-cancer risk.

Authors:  Charles M Ewing; Anna M Ray; Ethan M Lange; Kimberly A Zuhlke; Christiane M Robbins; Waibhav D Tembe; Kathleen E Wiley; Sarah D Isaacs; Dorhyun Johng; Yunfei Wang; Chris Bizon; Guifang Yan; Marta Gielzak; Alan W Partin; Vijayalakshmi Shanmugam; Tyler Izatt; Shripad Sinari; David W Craig; S Lilly Zheng; Patrick C Walsh; James E Montie; Jianfeng Xu; John D Carpten; William B Isaacs; Kathleen A Cooney
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

Review 2.  Morphogenetic fields in embryogenesis, regeneration, and cancer: non-local control of complex patterning.

Authors:  Michael Levin
Journal:  Biosystems       Date:  2012-04-20       Impact factor: 1.973

3.  HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease.

Authors:  John S Witte; Joel Mefford; Sarah J Plummer; Jinghua Liu; Iona Cheng; Eric A Klein; Benjamin A Rybicki; Graham Casey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-08       Impact factor: 4.254

4.  HOXB13 mutations in a population-based, case-control study of prostate cancer.

Authors:  Marni Stott-Miller; Danielle M Karyadi; Tiffany Smith; Erika M Kwon; Suzanne Kolb; Janet L Stanford; Elaine A Ostrander
Journal:  Prostate       Date:  2012-11-05       Impact factor: 4.104

5.  MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.

Authors:  Calvin VanOpstall; Srikanth Perike; Hannah Brechka; Marc Gillard; Sophia Lamperis; Baizhen Zhu; Ryan Brown; Raj Bhanvadia; Donald J Vander Griend
Journal:  Elife       Date:  2020-06-18       Impact factor: 8.140

6.  The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.

Authors:  Mohammad R Akbari; Wojciech Kluźniak; Rachelle Rodin; Song Li; Dominika Wokołorczyk; Robert Royer; Aniruddh Kashyap; Janusz Menkiszak; Jan Lubinski; Steven A Narod; Cezary Cybulski
Journal:  Breast Cancer Res Treat       Date:  2012-10-26       Impact factor: 4.872
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.